26.08.2019 08:30:00
|
Reminder: C-RAD Web Presentation Half-Year Report 2019
Presentation of the report for the first half of the fiscal year 2019:
Date: Friday August 30, 2019 / kl. 11:00
Venue: Online Presentation
Topic: C-RAD Half-year report 2019
Procedure:
Please register online through the website:
https://attendee.gotowebinar.com/register/5659643046196070669
After your registration, you will receive a confirmation via email.
A recording of the presentation will be made accessible on the C-RAD website after the presentation.
About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on Nasdaq Stockholm.
For more information on C-RAD, please visit www.c-rad.com
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com
Attachment
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu C-Rad AB -B-mehr Nachrichten
06.02.25 |
Ausblick: C-Rad -B- präsentiert Quartalsergebnisse (finanzen.net) | |
23.01.25 |
Erste Schätzungen: C-Rad -B- legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
22.10.24 |
Ausblick: C-Rad -B- stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
08.10.24 |
Erste Schätzungen: C-Rad -B- gewährt Anlegern Blick in die Bücher (finanzen.net) |
Analysen zu C-Rad AB -B-mehr Analysen
Aktien in diesem Artikel
C-Rad AB -B- | 31,40 | -1,41% |
|